Pages
- About Us
- Asbestos
- Asbestos Exposure
- Asbestos Exposure Liable Parties
- Asbestos-Containing Products and Their Risks
- Hidden Dangers of Secondary Asbestos Exposure
- High-Risk Industries for Asbestos Exposure
- Occupational Asbestos Exposure
- Asbestos Exposure Among Construction Workers
- Asbestos Exposure and Shipyard Workers
- Asbestos Exposure for Electricians
- Asbestos Exposure in Asbestos Mine Workers
- Asbestos Exposure in Asbestos Plant Workers
- Asbestos Exposure in Auto Mechanics
- Asbestos Exposure in Automakers
- Asbestos Exposure in Blacksmiths
- Asbestos Exposure in Boilermakers
- Asbestos Exposure in Bricklayers
- Asbestos Exposure in Carpenters
- Asbestos Exposure in Cement Plant Workers
- Asbestos Exposure in Chemical Plant Workers
- Asbestos Exposure in Firefighters
- Asbestos Exposure in Metal Workers
- Asbestos Exposure in Mine Workers
- Asbestos Exposure in Oil Refinery Workers
- Asbestos Exposure in Railroad Workers
- Asbestos Exposure in Steel Mills
- Asbestos Exposure Risks for Drywall Installers
- Asbestos Exposure Risks for Plumbers
- How Asbestos Exposure in Power Plants Works
- Asbestos Related Lung Cancer
- Disclaimer
- Editorial Guidelines
- Home
- Mesothelioma and Asbestos Lawyers
- Mesothelioma and Veterans
- Mesothelioma Cancer
- Mesothelioma Causes and Risk Factors
- Mesothelioma Cell Types: A Comprehensive Guide
- Mesothelioma Diagnosis
- Mesothelioma Facts & Statistics
- Mesothelioma Latency Period
- Mesothelioma Life Expectancy
- Mesothelioma Misdiagnosis
- Mesothelioma Support and Resources for Patients
- Mesothelioma Survival Rate
- Pericardial Mesothelioma
- Peritoneal Mesothelioma
- Pleural Mesothelioma
- Prognosis for Mesothelioma
- Stages of Mesothelioma
- What Are the Symptoms of Mesothelioma
- Mesothelioma Lawyer Case Review
- Mesothelioma Treatment
- Alternative Treatments for Mesothelioma
- Chemotherapy Treatment for Mesothelioma
- Clinical Trials for Mesothelioma
- Cost of Treating Mesothelioma
- Finding the Right Mesothelioma Specialists in the US
- Immunotherapy Treatment for Mesothelioma
- Mesothelioma Cure: Research, Treatments, and Progress
- Radiation Therapy for Mesothelioma
- Surgical Treatment for Mesothelioma
- Privacy Policy
- Sitemap
- Talcum Powder and Cancer
Posts
Advocacy
- ADAO Gains Support in Fight for Broader EPA Asbestos Ban
- ADRI’s ‘Meso March in May’ to Support Mesothelioma Patients
- Advocate Says The Fight To Ban Asbestos In The United States Isn’t Over
- Asbestos Still Kills As It Takes 30 Years For Mesothelioma to Develop
- Belluck & Fox LLP Expands to Boston to Tackle Asbestos Cases in New England
- Mesothelioma Awareness Day: Celebrate Advancements in Mesothelioma
- Why Hasn’t the United States Banned Asbestos?
Awareness
- 15 Years Later, 9/11 Still Claiming Lives of First Responders
- 15,000 Asbestos Deaths Per Year in the United States
- A Nation Infected by the Mine of One Small Montana Town in Libby
- Advocate Says The Fight To Ban Asbestos In The United States Isn’t Over
- Arizona Veterans: The Persistent Danger of Asbestos Exposure
- Asbestos Discovered at Essendon North Primary School
- Asbestos found in talc-based cosmetics, per new study
- Asbestos imports are getting closer and closer to causing a worldwide impact
- Asbestos Imports Shoot Up 74 Percent Year-Over-Year, Report Says
- Asbestos Imports Soar 2,000% as Trump Loosens Restrictions
- Asbestos Issues and Mesothelioma in Australia
- Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds
- Asbestos Spy Infiltrates Groups Pursuing Ban
- Asbestos Use and Its Implications in China
- California Courts Rule For Right to Sue Employer For Asbestos Exposure
- Cancer Patients and Caregivers: Mesothelioma
- Cancer-Causing Asbestos Found in Children’s Eye Shadow
- Children Exposed to Asbestos From Contaminated Soil
- City of San Diego Facing Continued Asbestos Lawsuits
- CNN chief anchor Amanpour reveals cancer diagnosis, surgery
- Decline in Asbestos Suits Escalated in 2020, Report Finds
- EPA Seeks Public Input for Asbestos Risk Evaluation
- Evidence Suggests FDA Could Take Johnson and Johnson’s Baby Powder Off the Market
- FDA Confirms Asbestos Contaminated Talc in Marie Claire’s Cosmetics
- Guilty Plea in Asbestos Release Case at Former IBM Site
- Have You Been Exposed to Cancer-Causing Asbestos?
- Healing Heroes: Expanding VA Support for Asbestos-Exposed Veterans
- Health Risks Exposed After the Johnson & Johnson Talc Powder Lawsuits
- High asbestos levels have been found in the state Cultural Building, Augusta
- How Your Occupation Can Put You At Risk for Asbestos Exposure
- Inadequate New EPA Rule Far From Complete Asbestos Ban
- Is Asbestos in Water a Widespread Health Threat?
- J & J Knew of Carcinogenic Asbestos in its Baby Powder for Decades
- J&J Trial: Expert Witness on Dangers of Talc
- Lung cancer death rate down 25% Since 1991 According to January Report
- Mesothelioma Awareness Day: Celebrate Advancements in Mesothelioma
- More than 9,000 Americans die yearly from asbestos exposure, latest data shows
- NovoTTF-100LTM and Chemotherapy Approved by FDA
- OSHA Proposed Rules Look To Revise Asbestos Danger Labels
- Repeal of the Affordable Care Act Would Be A Disaster For Asbestos Victims
- Report: Industry-Funded Asbestos Research Often Distorts Risks
- Report: Mesothelioma Is Being Diagnosed in More Women and Later in Life
- Researcher: Burying Asbestos in Sludge Is Not as Safe as We Thought
- Rising Mesothelioma Cases in Senior Women: Two Decades of Concern
- Seattle Area Asbestos Removal Contractor Fined $800K For Safety Violations
- Secondary Exposure Emerges as a Hidden Threat in the Ongoing Asbestos Crisis
- Senate Sets April 1-7 as National Asbestos Awareness Week
- Study Finds Asbestos Fibers Can Move in Soil, Challenging Current Clean-Up Strategy
- Study Finds State-Level Trends and Asbestos-Talc Risks
- Study Linking Asbestos Talc, Ovarian Cancer Puts Pressure on J&J
- Study Reveals Strong Link Between Low-Level Radon Exposure and Lung Cancer
- Study Shows How Military Veterans Deal With Mesothelioma
- Supporters of U.S. asbestos ban still optimistic
- Survey Says Over Half of Cargo Ships Still Contain Asbestos
- The Asbestos Lawsuit Process: From Diagnosis to Legal Action
- Trump EPA Moves to Shield Info on Asbestos Imports and Use from Public
- Trump’s Nominee For Head of EPA Plans to Gut Regulation & Protections
- Use of Talcum Powder Alter Molecular Mechanism of Ovarian Cancer Cells
- What a Trump Presidency Means to Asbestos Victims
- What Does the Rotterdam Convention Have to Do with Asbestos?
- WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns
- Why Hasn’t the United States Banned Asbestos?
Exposure Bans
- $25 Million Settlement Reached for Libby Montana Asbestos Exposure Victims
- 15,000 Asbestos Deaths Per Year in the United States
- 2 more enter a guilty plea in New York asbestos mishandling
- Asbestos Spy Infiltrates Groups Pursuing Ban
- California Courts Rule For Right to Sue Employer For Asbestos Exposure
- Canada Plans to Ban Asbestos Completely by 2018
- Children Exposed to Asbestos From Contaminated Soil
- Companies Hit With $75,000 Over Asbestos Handling
- EPA Shelves Risk Evaluation Model That Guided First Asbestos Review
- EPA To Outline Plans for Next Asbestos Risk Review This Summer
- EPA to Require More Asbestos Data from Importers
- EPA’s Asbestos Ban: Not Enough to End Cancer for Workers
- Evidence Suggests FDA Could Take Johnson and Johnson’s Baby Powder Off the Market
- Feds File Criminal Charges For Asbestos Exposure Near Mile High Stadium
- Groups Push Back on EPA’s Effort to Neuter Asbestos Reporting Order
- Guilty Plea in Asbestos Release Case at Former IBM Site
- Have You Been Exposed to Cancer-Causing Asbestos?
- Head of Asbestos Abatement Firm Pleads Guilty to Mishandling Asbestos
- Historic Victory: EPA Seals the Fate of Asbestos in America
- Inadequate New EPA Rule Far From Complete Asbestos Ban
- J&J Trial: Expert Witness on Dangers of Talc
- Lawmakers Seek New Restrictions on Asbestos Exposure Claims
- N.Y. Man To Settle EPA Complaint Over Asbestos Dumping for $135,000
- OSHA Proposed Rules Look To Revise Asbestos Danger Labels
- Researcher: Burying Asbestos in Sludge Is Not as Safe as We Thought
- Survey Says Over Half of Cargo Ships Still Contain Asbestos
- The End of Asbestos: EPA’s Historic Ban and Its Implications
- Use of Talcum Powder Alter Molecular Mechanism of Ovarian Cancer Cells
Featured
- $39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc
- $59.7M Transfer Triggers Legal Battle Over Asbestos Claims
- $8M Verdict Against Railway That Spilled Asbestos Material Upheld
- 15,000 Asbestos Deaths Per Year in the United States
- ADAO Gains Support in Fight for Broader EPA Asbestos Ban
- Arizona Veterans: The Persistent Danger of Asbestos Exposure
- Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds
- CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma
- Court Doubles Pabst’s Mesothelioma Payout to $13.4M
- Court Upholds Denial of Johnson & Johnson’s Bankruptcy Plan
- EPA’s Asbestos Ban: Not Enough to End Cancer for Workers
- FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
- FDA Prioritizes Keytruda-Chemo Combo for Mesothelioma Patients
- Florida Jury Hears Opening Statements Against Johnson & Johnson
- GAG-DP Biomaterial Advances Mesothelioma Research
- Harvard Study Offers Hope for Women with Pleural Mesothelioma
- Healing Heroes: Expanding VA Support for Asbestos-Exposed Veterans
- Historic $260M Verdict Against J&J in Asbestos-Tainted Talc Case
- Historic Victory: EPA Seals the Fate of Asbestos in America
- Illinois Jury Awards $45M in J&J Baby Powder Case
- Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
- J&J Agrees to Settle Consumer Deception Claims for $700 Million
- J&J Faces New Mesothelioma Trial in Texas Over Talc Claims
- J&J Proposes $505 Million Settlement With Talc Suppliers
- J&J Raises Talcum Powder Settlement by Another $1.1 Billion
- J&J Reportedly Has Enough Votes for $6.5B Settlement of Ovarian Cancer Lawsuits
- J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement
- J&J’s Talc Legal Battles: Medical Monitoring and Settlement
- Judge Dismisses Bid to Block J&J’s $6.48B Talc Settlement
- Judge Halts Most J&J Talc Lawsuits In Bankruptcy Settlement Push
- Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case
- Jury Awards $15M in Mesothelioma Verdict Against R.T. Vanderbilt
- Justice Served: Family Wins $24.4M in Avon Asbestos Talc Lawsuit
- Lawmakers Aim to Halt J&J’s Texas Two-Step Tactics
- Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder
- Mesothelioma Detection Gets a Boost with Mayo Clinic’s Innovative Blood Test
- Miami Judge Declares Mistrial in Ovarian Cancer Case filed against J&J talc
- PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma
- Pleural and Peritoneal Mesothelioma Found in Female Patient
- Promising Immunotherapy Case for Peritoneal Mesothelioma
- Rising Mesothelioma Cases in Senior Women: Two Decades of Concern
- Study Confirms Ki67 Predicts Mesothelioma Treatment Success
- Study Finds Cancer Link in Talc, Pressuring J&J’s $6.5 Billion Settlement Plan
- Study Linking Asbestos Talc, Ovarian Cancer Puts Pressure on J&J
- Talc Lung Cancer Lawsuit Costs Johnson & Johnson $63.4 Million
- Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J
- The Asbestos Lawsuit Process: From Diagnosis to Legal Action
- WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns
- Women File Class Action Suit Over J&J’s Attempts to Evade Talc Claims
Legislation
- Advocate Says The Fight To Ban Asbestos In The United States Isn’t Over
- California Courts Rule For Right to Sue Employer For Asbestos Exposure
- Canada Looks To Tighten Restrictions on Talc Over Health Risks
- Coalition Pushes Court to Overturn Asbestos Report as Inadequate
- EPA Would Restore Asbestos Reporting Rules Under Planned Settlement
- FDA Holds First Public Hearings on Talc-Asbestos Link
- FDA to announce new recommendations for testing Talc for Asbestos
- Insurers Challenge Cyprus Mines’ Choice for Claims Representative
- J&J Trial: Expert Witness on Dangers of Talc
- Johnson & Johnson CEO Testifies in Asbestos Cancer Lawsuit
- Lawmakers Seek New Restrictions on Asbestos Exposure Claims
- Massachusetts Legislature to Extend Asbestos Claim Deadline
- Miss. High Court Refuses to Toss Talcum Labeling Suit Against J&J
- N.Y. Supreme Court Says Asbestos Case Can’t Be Summarily Dismissed
- Repeal of the Affordable Care Act Would Be A Disaster For Asbestos Victims
- Senate committee OKs lead, asbestos removal incentives bill
- Supporters of U.S. asbestos ban still optimistic
- Tort Reform and Deregulation Issues Possibly Facing Mesothelioma Patients
- Will GOP Super Majority Pass the FACT Act?
News
- $15 Million Awarded in Mesothelioma Case Against Kaiser Gypsum Co. Inc.
- $25 Million Settlement Reached for Libby Montana Asbestos Exposure Victims
- $26.6M Verdict Stands in Mesothelioma Battle against Copeland
- $39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc
- $4.8M Verdict Against Whittaker Clark & Daniels in Mesothelioma Case
- $59.7M Transfer Triggers Legal Battle Over Asbestos Claims
- $80 Million Settlement Reached in Jackson County Courthouse Case
- $8M Verdict Against Railway That Spilled Asbestos Material Upheld
- 15 Years Later, 9/11 Still Claiming Lives of First Responders
- 15,000 Asbestos Deaths Per Year in the United States
- 2 more enter a guilty plea in New York asbestos mishandling
- 65-Year-Old Asbestos Victim Awarded $8.75 Million in Mesothelioma Lawsuit
- A Nation Infected by the Mine of One Small Montana Town in Libby
- Acupuncture and CBT Are Effective Treatments for Insomnia
- ADAO Gains Support in Fight for Broader EPA Asbestos Ban
- Advanced Radiotherapy Doubles Survival Time of Mesothelioma Patients
- Advancements in Mesothelioma Care: The Role of Hormonal Therapy
- Advocate Says The Fight To Ban Asbestos In The United States Isn’t Over
- AI Enhances Lung Nodule Cancer Prediction on CT Scans
- AI Reveals Mesothelioma Can Develop Along Predictable Pathways
- American International Appeals Subpoena Ruling in Talc Mesothelioma Case
- Appeals Court Rules Against Companies in Asbestos-Related Wrongful Death Suit
- Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
- Arizona Veterans: The Persistent Danger of Asbestos Exposure
- Asbestos Discovered at Essendon North Primary School
- Asbestos found in talc-based cosmetics, per new study
- Asbestos imports are getting closer and closer to causing a worldwide impact
- Asbestos Imports Shoot Up 74 Percent Year-Over-Year, Report Says
- Asbestos Imports Soar 2,000% as Trump Loosens Restrictions
- Asbestos insurance liability lawsuit sent to Montana Supreme Court
- Asbestos Issues and Mesothelioma in Australia
- Asbestos Lawsuit Returns to State Court Following Boeing’s Exit
- Asbestos Litigation Trends Reveal Ongoing Health Crisis, Study Finds
- Asbestos Spy Infiltrates Groups Pursuing Ban
- Asbestos Still Kills As It Takes 30 Years For Mesothelioma to Develop
- Asbestos Trust Worth $610 Million Forming From Ashes of Bankruptcy
- Asbestos Use and Its Implications in China
- Avelumab Treatment for Mesothelioma Patients Displays Positive Results
- Bankrupt Johnson & Johnson Talc Unit Defends Chapter 11 Move Amid Controversy
- Bankruptcy Judge Approves J&J’s ‘Stooge’ Talc Subsidiary in Legal Maneuver
- Bankruptcy Judge Denies Request for Talc Claim Trial Against Johnson & Johnson
- Bankruptcy Judge Reverses Split of J&J Tort Committee in Talc Spinoff Case
- Bankruptcy Judge Sanctions Asbestos Claimants in Bestwall LLC Case
- BDNF Protein as a Potential Target for Mesothelioma Treatment
- Belluck & Fox LLP Expands to Boston to Tackle Asbestos Cases in New England
- Bio-Inspired Drug Enhances Immune Response Against Cancer
- Bioengineers at UC San Diego Develop Ultrasound-Powered Cancer Immunotherapy
- Breaking Down the J&J Talc Settlement by State: Who Gets What?
- Breaking Research: EphB4 Regulation as a Treatment for Mesothelioma
- Breaking Research: Treatment for Resistant Ovarian Cancer
- Breakthrough Treatment: Eliminating Advanced-Stage Cancer in Mice
- California Courts Rule For Right to Sue Employer For Asbestos Exposure
- California Jury Awards $18.8 Million to Mesothelioma Patient In J&J Suit
- California Jury Grants $107M to Janitor’s Family for Asbestos Death
- Canada Looks To Tighten Restrictions on Talc Over Health Risks
- Canada Plans to Ban Asbestos Completely by 2018
- Cancer Patients and Caregivers: Mesothelioma
- Cancer Victims Motion Judge to Block J&J’s Bankruptcy Settlement
- Cancer-Causing Asbestos Found in Children’s Eye Shadow
- CAR T-cell Therapy Shows Promising Results for Treating Pleural Mesothelioma Patients
- Chapter 11 Dismissal Trial Key in J&J Talc Case
- Chemical company, law firm settle lawsuit over asbestos in talc products
- Chemoimmunotherapy is “Next Frontier” for Mesothelioma Treatment
- Children Exposed to Asbestos From Contaminated Soil
- Chinese Research Suggests SMRP is the Leading Biomarker
- CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma
- City of San Diego Facing Continued Asbestos Lawsuits
- CNN chief anchor Amanpour reveals cancer diagnosis, surgery
- Coalition Pushes Court to Overturn Asbestos Report as Inadequate
- Companies Hit With $75,000 Over Asbestos Handling
- Connecticut Jury Awards $20M in Mesothelioma Case
- Corporate Maneuvers in Bankruptcy Cases Draw Scrutiny
- Court Doubles Pabst’s Mesothelioma Payout to $13.4M
- Court Reinstates $3.6M Verdict For Woman Who Died on Eve of Trial
- Court Upholds Denial of Johnson & Johnson’s Bankruptcy Plan
- Covil Corp.’s Victory in Mesothelioma Wrongful Death Suit
- CT Scanning Not Reliable for Correct Diagnosis of Pleural Mesothelioma, says new study
- CT-Detected Emphysema Raises Lung Cancer Risk: Study
- Decision Postponed on Whether Talc Spinoff Stay Shelters J&J
- Decline in Asbestos Suits Escalated in 2020, Report Finds
- DNA Sequencing Test Proves Effective in Detecting Mesothelioma
- Dow Chemical Unit Wins New Trial in Mesothelioma Case
- Drug Combo Offers Promising Responses for Peritoneal Mesothelioma Patients
- E.U. Medical Authority Backs Immunotherapy Combo for Mesothelioma
- Early RSO-021 Clinical Trial Provides Hope for Mesothelioma Patients
- Emerging T-cell Therapy for Mesothelioma Shows Tumor Reduction
- EPA Seeks Public Input for Asbestos Risk Evaluation
- EPA Shelves Risk Evaluation Model That Guided First Asbestos Review
- EPA To Outline Plans for Next Asbestos Risk Review This Summer
- EPA to Require More Asbestos Data from Importers
- EPA Would Restore Asbestos Reporting Rules Under Planned Settlement
- EPA’s Asbestos Ban: Not Enough to End Cancer for Workers
- Evidence Suggests FDA Could Take Johnson and Johnson’s Baby Powder Off the Market
- Exploring How Asbestos Reacts Inside Cells: A New Perspective
- Family of Deceased Navy Worker Receives Asbestos Wrongful Death Settlement from Goodyear
- FCCI Insurance Seeks Exclusion in Asbestos Lawsuits
- FDA approved phase I clinical trials of CAR T-cell therapy
- FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma
- FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
- FDA Confirms Asbestos Contaminated Talc in Marie Claire’s Cosmetics
- FDA Holds First Public Hearings on Talc-Asbestos Link
- FDA Prioritizes Keytruda-Chemo Combo for Mesothelioma Patients
- FDA to announce new recommendations for testing Talc for Asbestos
- FDA to Fast Track Norwegian Firm’s Mesothelioma Candidate
- Feds File Criminal Charges For Asbestos Exposure Near Mile High Stadium
- Fifth Circuit Breathes New Life into Asbestos Suit Against Boeing
- First-Ever T-Cell Therapy for Solid Tumors shows Remarkable Results
- Florida Appeals Court Reopens Mesothelioma Case Against Carlisle
- Florida Court Stands by Mesothelioma Wrongful Death Precedent
- Florida Jury Hears Opening Statements Against Johnson & Johnson
- Fluorescent Nanoprobes Light Up Peritoneal Mesothelioma During Surgery
- Fourth Circuit Denies Appeal in Asbestos-Laden Talc Lawsuit
- GAG-DP Biomaterial Advances Mesothelioma Research
- Genetic Expression Could Aid Diagnosis of Sarcomatoid Mesothelioma
- Georgia Widow Seeks to Transfer Roundup Lawsuit Back to State Court
- Groundbreaking Therapy Enhances Lifespan in Mesothelioma Trials
- Groups Push Back on EPA’s Effort to Neuter Asbestos Reporting Order
- Guilty Plea in Asbestos Release Case at Former IBM Site
- Harvard Study Offers Hope for Women with Pleural Mesothelioma
- Have You Been Exposed to Cancer-Causing Asbestos?
- Head of Asbestos Abatement Firm Pleads Guilty to Mishandling Asbestos
- Healing Heroes: Expanding VA Support for Asbestos-Exposed Veterans
- Health Risks Exposed After the Johnson & Johnson Talc Powder Lawsuits
- Hess Corp. Settles Asbestos Claims for $106 Million
- High asbestos levels have been found in the state Cultural Building, Augusta
- Historic $260M Verdict Against J&J in Asbestos-Tainted Talc Case
- Historic Victory: EPA Seals the Fate of Asbestos in America
- How Your Occupation Can Put You At Risk for Asbestos Exposure
- Illinois Jury Awards $45M in J&J Baby Powder Case
- Immunotherapy Combo Can Improve Survival Time for Relapsed Mesothelioma
- Immunotherapy Drug Buys Relapsed Mesothelioma Patients More Time
- Inadequate New EPA Rule Far From Complete Asbestos Ban
- Increased Survival Rate in Finnish Peritoneal Mesothelioma Patients
- Inhibition of IDH1 protein can Halt Ovarian Cancer, says new research
- Innovative Cancer Therapy Brings Hope to Mesothelioma Patients
- Insurers Challenge Cyprus Mines’ Choice for Claims Representative
- Is Asbestos in Water a Widespread Health Threat?
- Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
- J & J Knew of Carcinogenic Asbestos in its Baby Powder for Decades
- J&J Agrees to Settle Consumer Deception Claims for $700 Million
- J&J and Beasley Allen Clash Over $6.48 Billion Talc Settlement
- J&J Appeals $2.1 Billion Talc Judgment to Supreme Court
- J&J Delays Appeal of $2.1 Billion Verdict Over COVID-19 Issues
- J&J Faces New Mesothelioma Trial in Texas Over Talc Claims
- J&J Proposes $505 Million Settlement With Talc Suppliers
- J&J Raises Talcum Powder Settlement by Another $1.1 Billion
- J&J Reportedly Has Enough Votes for $6.5B Settlement of Ovarian Cancer Lawsuits
- J&J Reserves Nearly $4 Billion for Talc-Based Lawsuits
- J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement
- J&J Talc Unit Says Ch. 11 Only Recovery Option For Claimants
- J&J Talc Unit’s Bankruptcy Trial Unveils Multibillion-Dollar Battle
- J&J Trial: Expert Witness on Dangers of Talc
- J&J’s Talc Legal Battles: Medical Monitoring and Settlement
- Johnson & Johnson CEO Testifies in Asbestos Cancer Lawsuit
- Johnson & Johnson Criticized for Controversial Bankruptcy Maneuver
- Johnson & Johnson Faces Critical Legal Test in Connecticut
- Johnson & Johnson Talc Mesothelioma Lawsuit Awards Plaintiff $29M
- Johnson & Johnson to pay out over $120 million in damages, per New York court
- Johnson & Johnson’s Bankrupt Talc Subsidiary Faces Courtroom Showdowns
- Johnson & Johnson’s Bankrupt Talc Unit Survives Dismissal Bid
- Judge Dismisses Bid to Block J&J’s $6.48B Talc Settlement
- Judge Halts Most J&J Talc Lawsuits In Bankruptcy Settlement Push
- Judge Rejects Consolidation of Dow Mesothelioma Cases
- Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case
- Judge Rules Ford Not Liable in Mesothelioma Lawsuit Due to Prior Settlements
- Jury Awards $15M in Mesothelioma Verdict Against R.T. Vanderbilt
- Jury Awards $17M in Compensation for Asbestos-Related Disease Against Georgia-Pacific
- Jury Awards $25 million in Testicular Mesothelioma Lawsuit
- Jury Awards $50 Million To a Woman in Talc Lawsuit Against Avon
- Jury Awards $750 Million in Damages Against Johnson & Johnson
- Jury Awards $75M in Largest Mesothelioma Verdict in New York History
- Jury Awards Veteran With Mesothelioma $4.8 Million
- Jury Trial Underway in Case of Man Who Blames J&J Baby Powder For His Mesothelioma
- Justice Served: Family Wins $24.4M in Avon Asbestos Talc Lawsuit
- Largest Recorded Individual Lawsuit For Asbestos Exposure Awarded To Mississippi Man
- Law Professors Say J&J Talc Ch. 11 Is Shielding Assets
- Lawmakers Aim to Halt J&J’s Texas Two-Step Tactics
- Lawmakers Seek New Restrictions on Asbestos Exposure Claims
- Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder
- Legal Scholars Urge Dismissal of Johnson & Johnson Talc Unit’s Chapter 11 Case
- Low-Dose CT Screening May Increase Life Expectancy of Pleural Mesothelioma Patients
- Lumicell Technology Improves Efficiency of Mesothelioma Treatment
- Lung Biopsy is Crucial for Distinction Between Asbestos-Related Cancers
- Lung cancer death rate down 25% Since 1991 According to January Report
- Madison County, IL Leads Nation in Asbestos Filings
- Maintenance Gemcitabine Can Delay Mesothelioma’s Progression
- Maintenance Therapies After Ovarian Cancer Treatment- Efficient But Expensive
- Massachusetts Legislature to Extend Asbestos Claim Deadline
- Mayo Clinic Validates Genomic Approach in Treating Gastric Cancer
- Mechanic’s Exposure to Asbestos Leads to Wrongful Death Mesothelioma Claim
- MesoPher Vaccine May Improve Efficacy of Mesothelioma Treatments
- Mesothelioma Awareness Day: Celebrate Advancements in Mesothelioma
- Mesothelioma Clinical Trial Seeking Patients for Study of New Cancer Drug
- Mesothelioma Detection Gets a Boost with Mayo Clinic’s Innovative Blood Test
- Mesothelioma Settlements Amounts on the Rise Compared to a Decade Ago: Reuters
- Miami Judge Declares Mistrial in Ovarian Cancer Case filed against J&J talc
- Miss. High Court Refuses to Toss Talcum Labeling Suit Against J&J
- More than 9,000 Americans die yearly from asbestos exposure, latest data shows
- Mouse Study Reveals Potential Breakthrough in Pulmonary Fibrosis Treatment
- Mutated Gene Could Predict Chemoresistance in Mesothelioma Patients
- N.Y. Man To Settle EPA Complaint Over Asbestos Dumping for $135,000
- N.Y. Supreme Court Says Asbestos Case Can’t Be Summarily Dismissed
- Nanoparticle Therapy Revolutionizes Cancer Treatment
- Navy Sailor’s Mesothelioma Lawsuit Targets Foster Wheeler
- New ‘Interactome’ Maps Out Genetic Interactions in Mesothelioma
- New Delivery Method Cuts Mesothelioma Tumor Growth Significantly
- New Hope for Mesothelioma: Breakthroughs in Treatment Research
- New Jersey appeals court ruling could revive 1,000 talc lawsuits
- New Jersey Appeals Panel Upholds Sanctions Against Ford in Asbestos Trial
- New Jersey Judge Permits Amicus Briefs in Johnson & Johnson Talc Bankruptcy Case
- New Mesothelioma Treatment Era with ADI-PEG20
- New Study Shows Surgery Can Improve Prognosis with Peritoneal Mesothelioma
- Niraparib Extends Life of Ovarian Cancer Patients, Says New Study
- NJ High Court Skeptical Of Union Carbide Asbestos Verdict
- NJ Judge Approves Limited Legal Fees in J&J Talc Bankruptcy
- Nomogram Can Replace TNM Staging for Predicting Survival of Pleural Mesothelioma
- North Carolina Couple Drops Defendants in Asbestos Lawsuit
- North Carolina Families Seek to Consolidate Asbestos Lawsuits
- NovoTTF-100LTM and Chemotherapy Approved by FDA
- Ohio Jury Grants $15M in Mesothelioma Compensation for Family Members
- Ohio man’s estate gets $12.1 million in mesothelioma lawsuit
- Oklahoma Appeals Court Holds Firm on $8 Million Mesothelioma Verdict
- ONCOS-102 immunotherapy vaccine could benefit mesothelioma patient recovery
- OSHA Proposed Rules Look To Revise Asbestos Danger Labels
- Ovarian Cancer Patients Can Now Access Tumor Blocking Drug
- Ovarian Cancer Patients Seek Representation in J&J Talc Bankruptcy Case
- PD- 1 CAR-T Cell Therapy is Safe and Toxicity Free
- PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma
- Phase III Clinical Trial For Mesothelioma Shows Tumor Shrinkage
- Pittsburgh Corning Forced to Pay $3.5 Billion in Asbestos Lung Cancer Lawsuit Settlements
- Pleural and Peritoneal Mesothelioma Found in Female Patient
- Pleural Mesothelioma Treatment Vivostat Using Gel-based Drug Delivery Method
- Promising Immunotherapy Case for Peritoneal Mesothelioma
- Proposed Talcum Powder Class-Action Suit Moves to Appeals Court
- Protein Testing May Aid in Diagnosing Mesothelioma, Research Shows
- Protein-Staining Test Can’t Distinguish Benign From Malignant Mesothelioma
- Repeal of the Affordable Care Act Would Be A Disaster For Asbestos Victims
- Report: Industry-Funded Asbestos Research Often Distorts Risks
- Report: Mesothelioma Is Being Diagnosed in More Women and Later in Life
- Research Started to Test Breath-based biomarkers for Mesothelioma Diagnosis
- Research Supports DHA Treatment as Effective for Pleural Mesothelioma Patients
- Research: Keyhole Surgery Better for Meso Patients in the Short Term
- Researcher Awarded $2.5 Million to Develop Immunotherapy Response Test
- Researcher: Burying Asbestos in Sludge Is Not as Safe as We Thought
- Researchers Identify Lymph Nodes As Significant Survival Indicator for Mesothelioma
- Researchers Train AI to Diagnose, Measure Mesothelioma Via Scan
- Researchers Use AI to Triage Patients With Chest Pain
- Reuters Holds Ground Against J&J’s Failed Blocking Attempt
- Rising Mesothelioma Cases in Senior Women: Two Decades of Concern
- Seattle Area Asbestos Removal Contractor Fined $800K For Safety Violations
- Secondary Exposure Emerges as a Hidden Threat in the Ongoing Asbestos Crisis
- Senate committee OKs lead, asbestos removal incentives bill
- Senate Sets April 1-7 as National Asbestos Awareness Week
- Seventh Circuit Reinstates Asbestos Packaging Lawsuit Against Kiln Manufacturer
- Sikorsky Aircraft Faces Class Action Lawsuit for Mesothelioma
- Spraying Oxaliplatin via PIPAC can Increase Survival of Peritoneal Mesothelioma
- Study Confirms Ki67 Predicts Mesothelioma Treatment Success
- Study Favors Chemo Over Surgery in Malignant Pleural Mesothelioma
- Study Finds Asbestos Fibers Can Move in Soil, Challenging Current Clean-Up Strategy
- Study Finds Cancer Link in Talc, Pressuring J&J’s $6.5 Billion Settlement Plan
- Study Finds Lung-Sparing Surgery Improves Mesothelioma Survival
- Study Finds Staining Tests Alone Can’t Reliably Diagnose Mesothelioma
- Study Finds State-Level Trends and Asbestos-Talc Risks
- Study Linking Asbestos Talc, Ovarian Cancer Puts Pressure on J&J
- Study Reveals Extended Survival Rate of Mesothelioma using EPP
- Study Reveals Strong Link Between Low-Level Radon Exposure and Lung Cancer
- Study Shows How Military Veterans Deal With Mesothelioma
- Study Uncovers Link Between Hormone Levels and Pleural Mesothelioma
- Study: Advanced Mesothelioma Cases Require ‘More Effective’ Therapies
- Study: Gene Mapping Technique Improves Pleural Mesothelioma Diagnosis
- Study: Immunotherapy Drug Buys Relapsed Meso Patients More Time
- Supporters of U.S. asbestos ban still optimistic
- Supreme Court rejects J&J plea to review $2.1 billion talc case
- Survey Says Over Half of Cargo Ships Still Contain Asbestos
- Talc Claimants Fight to Dismiss J&J Bankruptcy in High-Stakes Battle
- Talc Firms in Bankruptcy Prolong Settlement Mediation with Claimants
- Talc Injury Claimants Accuse J&J of Bankruptcy Maneuvering
- Talc Lung Cancer Lawsuit Costs Johnson & Johnson $63.4 Million
- Talc Producer Proposes $862.5M Trust to Settle Cancer Claims
- Talc Producer Settles Mesothelioma Case Mid-Trial for Unknown Amount
- Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J
- Talc Supplier Settles Mesothelioma Lawsuit Midtrial
- Talc Unit Fights for $8.9 Billion Bankruptcy Settlement
- Targeted phototherapy Shows low-risk and effective for Pleural Mesothelioma
- Targeting BCL-XL showed Impressive Development in Treating MPM
- Targovax’s Mesothelioma Candidate Shines in Latest Survival Data
- Team of Italian researchers suggest that three key biomarkers may be the key to response therapy
- The Asbestos Lawsuit Process: From Diagnosis to Legal Action
- The Cost of Powder: J&J’s $700 Million Leap to Settle Asbestos Cancer Claims
- The End of Asbestos: EPA’s Historic Ban and Its Implications
- Tort Reform and Deregulation Issues Possibly Facing Mesothelioma Patients
- Travelers Unit to Defend Cimbar in Mesothelioma Talc Lawsuit
- Trump EPA Moves to Shield Info on Asbestos Imports and Use from Public
- Trump’s Nominee For Head of EPA Plans to Gut Regulation & Protections
- Two Studies Examine Different Facets of Peritoneal Mesothelioma
- Ultrasound-Guided Needle Replaces Riskier Procedure
- Use of Talcum Powder Alter Molecular Mechanism of Ovarian Cancer Cells
- Viking Pump Inc. Moves to Dismiss NC Asbestos Lawsuit in NC
- Washington Appellate Upholds Mesothelioma Verdict Against Kaiser Gypsum
- Washington Court Upholds $17M Verdict in Mesothelioma Suit
- Washington Supreme Court Confirms $4M ExxonMobil Asbestos Verdict
- What a Trump Presidency Means to Asbestos Victims
- What Does the Rotterdam Convention Have to Do with Asbestos?
- Whittaker Clark & Daniels Files for Bankruptcy Amid Asbestos Lawsuit Fallout
- WHO Labels Talc as ‘Probably Carcinogenic,’ Raising Cancer Concerns
- Why Hasn’t the United States Banned Asbestos?
- Will GOP Super Majority Pass the FACT Act?
- Women File Class Action Suit Over J&J’s Attempts to Evade Talc Claims
- Wrongful Death Lawsuit for Mesothelioma Leads to $11M Jury Award
Research
- Advanced Radiotherapy Doubles Survival Time of Mesothelioma Patients
- Advancements in Mesothelioma Care: The Role of Hormonal Therapy
- AI Enhances Lung Nodule Cancer Prediction on CT Scans
- AI Reveals Mesothelioma Can Develop Along Predictable Pathways
- Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
- BDNF Protein as a Potential Target for Mesothelioma Treatment
- Bioengineers at UC San Diego Develop Ultrasound-Powered Cancer Immunotherapy
- Breaking Research: EphB4 Regulation as a Treatment for Mesothelioma
- Breakthrough Treatment: Eliminating Advanced-Stage Cancer in Mice
- CAR T-cell Therapy Shows Promising Results for Treating Pleural Mesothelioma Patients
- Chinese Research Suggests SMRP is the Leading Biomarker
- CT Scanning Not Reliable for Correct Diagnosis of Pleural Mesothelioma, says new study
- CT-Detected Emphysema Raises Lung Cancer Risk: Study
- DNA Sequencing Test Proves Effective in Detecting Mesothelioma
- Early RSO-021 Clinical Trial Provides Hope for Mesothelioma Patients
- Emerging T-cell Therapy for Mesothelioma Shows Tumor Reduction
- Exploring How Asbestos Reacts Inside Cells: A New Perspective
- FDA approved phase I clinical trials of CAR T-cell therapy
- FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
- First-Ever T-Cell Therapy for Solid Tumors shows Remarkable Results
- Fluorescent Nanoprobes Light Up Peritoneal Mesothelioma During Surgery
- GAG-DP Biomaterial Advances Mesothelioma Research
- Genetic Expression Could Aid Diagnosis of Sarcomatoid Mesothelioma
- Increased Survival Rate in Finnish Peritoneal Mesothelioma Patients
- Inhibition of IDH1 protein can Halt Ovarian Cancer, says new research
- Innovative Cancer Therapy Brings Hope to Mesothelioma Patients
- Low-Dose CT Screening May Increase Life Expectancy of Pleural Mesothelioma Patients
- Lumicell Technology Improves Efficiency of Mesothelioma Treatment
- Lung Biopsy is Crucial for Distinction Between Asbestos-Related Cancers
- Maintenance Gemcitabine Can Delay Mesothelioma’s Progression
- MesoPher Vaccine May Improve Efficacy of Mesothelioma Treatments
- Mesothelioma Clinical Trial Seeking Patients for Study of New Cancer Drug
- Mesothelioma Detection Gets a Boost with Mayo Clinic’s Innovative Blood Test
- Mouse Study Reveals Potential Breakthrough in Pulmonary Fibrosis Treatment
- Mutated Gene Could Predict Chemoresistance in Mesothelioma Patients
- New ‘Interactome’ Maps Out Genetic Interactions in Mesothelioma
- New Mesothelioma Treatment Era with ADI-PEG20
- Niraparib Extends Life of Ovarian Cancer Patients, Says New Study
- Nomogram Can Replace TNM Staging for Predicting Survival of Pleural Mesothelioma
- NovoTTF-100LTM and Chemotherapy Approved by FDA
- ONCOS-102 immunotherapy vaccine could benefit mesothelioma patient recovery
- PD- 1 CAR-T Cell Therapy is Safe and Toxicity Free
- Pleural and Peritoneal Mesothelioma Found in Female Patient
- Pleural Mesothelioma Treatment Vivostat Using Gel-based Drug Delivery Method
- Protein Reactivation Offers Insights into Mesothelioma Origins
- Protein Testing May Aid in Diagnosing Mesothelioma, Research Shows
- Protein-Staining Test Can’t Distinguish Benign From Malignant Mesothelioma
- Research Started to Test Breath-based biomarkers for Mesothelioma Diagnosis
- Research Supports DHA Treatment as Effective for Pleural Mesothelioma Patients
- Research: Keyhole Surgery Better for Meso Patients in the Short Term
- Researcher Awarded $2.5 Million to Develop Immunotherapy Response Test
- Researchers Identify Lymph Nodes As Significant Survival Indicator for Mesothelioma
- Researchers Train AI to Diagnose, Measure Mesothelioma Via Scan
- Researchers Use AI to Triage Patients With Chest Pain
- Significant Role of DFMO Treatment in Mesothelioma Adjuvant Therapy
- Study Confirms Ki67 Predicts Mesothelioma Treatment Success
- Study Favors Chemo Over Surgery in Malignant Pleural Mesothelioma
- Study Finds Staining Tests Alone Can’t Reliably Diagnose Mesothelioma
- Study Reveals Extended Survival Rate of Mesothelioma using EPP
- Study Uncovers Link Between Hormone Levels and Pleural Mesothelioma
- Study: Advanced Mesothelioma Cases Require ‘More Effective’ Therapies
- Study: Gene Mapping Technique Improves Pleural Mesothelioma Diagnosis
- Study: Immunotherapy Drug Buys Relapsed Meso Patients More Time
- Targeted phototherapy Shows low-risk and effective for Pleural Mesothelioma
- Targeting BCL-XL showed Impressive Development in Treating MPM
- Targovax’s Mesothelioma Candidate Shines in Latest Survival Data
- Team of Italian researchers suggest that three key biomarkers may be the key to response therapy
- Ultrasound-Guided Needle Replaces Riskier Procedure
Settlements
- $15 Million Awarded in Mesothelioma Case Against Kaiser Gypsum Co. Inc.
- $25 Million Settlement Reached for Libby Montana Asbestos Exposure Victims
- $26.6M Verdict Stands in Mesothelioma Battle against Copeland
- $39M Awarded In Mesothelioma Case Tied to Medical Contaminated Talc
- $4.8M Verdict Against Whittaker Clark & Daniels in Mesothelioma Case
- $59.7M Transfer Triggers Legal Battle Over Asbestos Claims
- $80 Million Settlement Reached in Jackson County Courthouse Case
- $8M Verdict Against Railway That Spilled Asbestos Material Upheld
- 65-Year-Old Asbestos Victim Awarded $8.75 Million in Mesothelioma Lawsuit
- American International Appeals Subpoena Ruling in Talc Mesothelioma Case
- Appeals Court Rules Against Companies in Asbestos-Related Wrongful Death Suit
- Asbestos insurance liability lawsuit sent to Montana Supreme Court
- Asbestos Lawsuit Returns to State Court Following Boeing’s Exit
- Asbestos Trust Worth $610 Million Forming From Ashes of Bankruptcy
- Bankrupt Johnson & Johnson Talc Unit Defends Chapter 11 Move Amid Controversy
- Bankruptcy Judge Approves J&J’s ‘Stooge’ Talc Subsidiary in Legal Maneuver
- Bankruptcy Judge Denies Request for Talc Claim Trial Against Johnson & Johnson
- Bankruptcy Judge Reverses Split of J&J Tort Committee in Talc Spinoff Case
- Bankruptcy Judge Sanctions Asbestos Claimants in Bestwall LLC Case
- Breaking Down the J&J Talc Settlement by State: Who Gets What?
- California Jury Awards $18.8 Million to Mesothelioma Patient In J&J Suit
- California Jury Grants $107M to Janitor’s Family for Asbestos Death
- Cancer Victims Motion Judge to Block J&J’s Bankruptcy Settlement
- Chapter 11 Dismissal Trial Key in J&J Talc Case
- Chemical company, law firm settle lawsuit over asbestos in talc products
- Connecticut Jury Awards $20M in Mesothelioma Case
- Corporate Maneuvers in Bankruptcy Cases Draw Scrutiny
- Court Doubles Pabst’s Mesothelioma Payout to $13.4M
- Court Reinstates $3.6M Verdict For Woman Who Died on Eve of Trial
- Court Upholds Denial of Johnson & Johnson’s Bankruptcy Plan
- Covil Corp.’s Victory in Mesothelioma Wrongful Death Suit
- Decision Postponed on Whether Talc Spinoff Stay Shelters J&J
- Dow Chemical Unit Wins New Trial in Mesothelioma Case
- Family of Deceased Navy Worker Receives Asbestos Wrongful Death Settlement from Goodyear
- FCCI Insurance Seeks Exclusion in Asbestos Lawsuits
- Fifth Circuit Breathes New Life into Asbestos Suit Against Boeing
- Florida Appeals Court Reopens Mesothelioma Case Against Carlisle
- Florida Court Stands by Mesothelioma Wrongful Death Precedent
- Florida Jury Hears Opening Statements Against Johnson & Johnson
- Fourth Circuit Denies Appeal in Asbestos-Laden Talc Lawsuit
- Georgia Widow Seeks to Transfer Roundup Lawsuit Back to State Court
- Hess Corp. Settles Asbestos Claims for $106 Million
- Historic $260M Verdict Against J&J in Asbestos-Tainted Talc Case
- Illinois Jury Awards $45M in J&J Baby Powder Case
- Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
- J&J Agrees to Settle Consumer Deception Claims for $700 Million
- J&J and Beasley Allen Clash Over $6.48 Billion Talc Settlement
- J&J Appeals $2.1 Billion Talc Judgment to Supreme Court
- J&J Delays Appeal of $2.1 Billion Verdict Over COVID-19 Issues
- J&J Faces New Mesothelioma Trial in Texas Over Talc Claims
- J&J Proposes $505 Million Settlement With Talc Suppliers
- J&J Raises Talcum Powder Settlement by Another $1.1 Billion
- J&J Reportedly Has Enough Votes for $6.5B Settlement of Ovarian Cancer Lawsuits
- J&J Reserves Nearly $4 Billion for Talc-Based Lawsuits
- J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement
- J&J Talc Unit Says Ch. 11 Only Recovery Option For Claimants
- J&J Talc Unit’s Bankruptcy Trial Unveils Multibillion-Dollar Battle
- J&J’s Talc Legal Battles: Medical Monitoring and Settlement
- Johnson & Johnson CEO Testifies in Asbestos Cancer Lawsuit
- Johnson & Johnson Criticized for Controversial Bankruptcy Maneuver
- Johnson & Johnson Faces Critical Legal Test in Connecticut
- Johnson & Johnson Talc Mesothelioma Lawsuit Awards Plaintiff $29M
- Johnson & Johnson to pay out over $120 million in damages, per New York court
- Johnson & Johnson’s Bankrupt Talc Subsidiary Faces Courtroom Showdowns
- Johnson & Johnson’s Bankrupt Talc Unit Survives Dismissal Bid
- Judge Dismisses Bid to Block J&J’s $6.48B Talc Settlement
- Judge Halts Most J&J Talc Lawsuits In Bankruptcy Settlement Push
- Judge Rejects Consolidation of Dow Mesothelioma Cases
- Judge Rejects J&J’s Fraud Allegations in Mesothelioma Talc Study Case
- Judge Rules Ford Not Liable in Mesothelioma Lawsuit Due to Prior Settlements
- Jury Awards $15M in Mesothelioma Verdict Against R.T. Vanderbilt
- Jury Awards $17M in Compensation for Asbestos-Related Disease Against Georgia-Pacific
- Jury Awards $25 million in Testicular Mesothelioma Lawsuit
- Jury Awards $50 Million To a Woman in Talc Lawsuit Against Avon
- Jury Awards $750 Million in Damages Against Johnson & Johnson
- Jury Awards $75M in Largest Mesothelioma Verdict in New York History
- Jury Awards Veteran With Mesothelioma $4.8 Million
- Jury Trial Underway in Case of Man Who Blames J&J Baby Powder For His Mesothelioma
- Justice Served: Family Wins $24.4M in Avon Asbestos Talc Lawsuit
- Largest Recorded Individual Lawsuit For Asbestos Exposure Awarded To Mississippi Man
- Law Professors Say J&J Talc Ch. 11 Is Shielding Assets
- Lawmakers Aim to Halt J&J’s Texas Two-Step Tactics
- Lawsuit Seeks Justice for Women at Risk from J&J Talc Powder
- Legal Scholars Urge Dismissal of Johnson & Johnson Talc Unit’s Chapter 11 Case
- Madison County, IL Leads Nation in Asbestos Filings
- Mechanic’s Exposure to Asbestos Leads to Wrongful Death Mesothelioma Claim
- Mesothelioma Settlements Amounts on the Rise Compared to a Decade Ago: Reuters
- Miami Judge Declares Mistrial in Ovarian Cancer Case filed against J&J talc
- Miss. High Court Refuses to Toss Talcum Labeling Suit Against J&J
- N.Y. Man To Settle EPA Complaint Over Asbestos Dumping for $135,000
- Navy Sailor’s Mesothelioma Lawsuit Targets Foster Wheeler
- New Jersey appeals court ruling could revive 1,000 talc lawsuits
- New Jersey Appeals Panel Upholds Sanctions Against Ford in Asbestos Trial
- New Jersey Judge Permits Amicus Briefs in Johnson & Johnson Talc Bankruptcy Case
- NJ High Court Skeptical Of Union Carbide Asbestos Verdict
- NJ Judge Approves Limited Legal Fees in J&J Talc Bankruptcy
- North Carolina Couple Drops Defendants in Asbestos Lawsuit
- North Carolina Families Seek to Consolidate Asbestos Lawsuits
- Ohio Jury Grants $15M in Mesothelioma Compensation for Family Members
- Ohio man’s estate gets $12.1 million in mesothelioma lawsuit
- Oklahoma Appeals Court Holds Firm on $8 Million Mesothelioma Verdict
- Ovarian Cancer Patients Seek Representation in J&J Talc Bankruptcy Case
- Pittsburgh Corning Forced to Pay $3.5 Billion in Asbestos Lung Cancer Lawsuit Settlements
- Proposed Talcum Powder Class-Action Suit Moves to Appeals Court
- Reuters Holds Ground Against J&J’s Failed Blocking Attempt
- Seventh Circuit Reinstates Asbestos Packaging Lawsuit Against Kiln Manufacturer
- Sikorsky Aircraft Faces Class Action Lawsuit for Mesothelioma
- Study Finds Cancer Link in Talc, Pressuring J&J’s $6.5 Billion Settlement Plan
- Supreme Court rejects J&J plea to review $2.1 billion talc case
- Talc Claimants Fight to Dismiss J&J Bankruptcy in High-Stakes Battle
- Talc Firms in Bankruptcy Prolong Settlement Mediation with Claimants
- Talc Injury Claimants Accuse J&J of Bankruptcy Maneuvering
- Talc Lung Cancer Lawsuit Costs Johnson & Johnson $63.4 Million
- Talc Producer Proposes $862.5M Trust to Settle Cancer Claims
- Talc Producer Settles Mesothelioma Case Mid-Trial for Unknown Amount
- Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J
- Talc Supplier Settles Mesothelioma Lawsuit Midtrial
- Talc Unit Fights for $8.9 Billion Bankruptcy Settlement
- The Cost of Powder: J&J’s $700 Million Leap to Settle Asbestos Cancer Claims
- Travelers Unit to Defend Cimbar in Mesothelioma Talc Lawsuit
- Viking Pump Inc. Moves to Dismiss NC Asbestos Lawsuit in NC
- Washington Appellate Upholds Mesothelioma Verdict Against Kaiser Gypsum
- Washington Court Upholds $17M Verdict in Mesothelioma Suit
- Washington Supreme Court Confirms $4M ExxonMobil Asbestos Verdict
- Whittaker Clark & Daniels Files for Bankruptcy Amid Asbestos Lawsuit Fallout
- Women File Class Action Suit Over J&J’s Attempts to Evade Talc Claims
- Wrongful Death Lawsuit for Mesothelioma Leads to $11M Jury Award
Treatment
- Acupuncture and CBT Are Effective Treatments for Insomnia
- Advanced Radiotherapy Doubles Survival Time of Mesothelioma Patients
- Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
- Avelumab Treatment for Mesothelioma Patients Displays Positive Results
- Bio-Inspired Drug Enhances Immune Response Against Cancer
- Bioengineers at UC San Diego Develop Ultrasound-Powered Cancer Immunotherapy
- Breaking Research: Treatment for Resistant Ovarian Cancer
- CAR T-cell Therapy Shows Promising Results for Treating Pleural Mesothelioma Patients
- Chemoimmunotherapy is “Next Frontier” for Mesothelioma Treatment
- Chinese Research Suggests SMRP is the Leading Biomarker
- CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma
- Drug Combo Offers Promising Responses for Peritoneal Mesothelioma Patients
- E.U. Medical Authority Backs Immunotherapy Combo for Mesothelioma
- Emerging T-cell Therapy for Mesothelioma Shows Tumor Reduction
- FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma
- FDA Prioritizes Keytruda-Chemo Combo for Mesothelioma Patients
- FDA to Fast Track Norwegian Firm’s Mesothelioma Candidate
- First-Ever T-Cell Therapy for Solid Tumors shows Remarkable Results
- Groundbreaking Therapy Enhances Lifespan in Mesothelioma Trials
- Harvard Study Offers Hope for Women with Pleural Mesothelioma
- Immunotherapy Combo Can Improve Survival Time for Relapsed Mesothelioma
- Immunotherapy Drug Buys Relapsed Mesothelioma Patients More Time
- Increased Survival Rate in Finnish Peritoneal Mesothelioma Patients
- Inhibition of IDH1 protein can Halt Ovarian Cancer, says new research
- Innovative Cancer Therapy Brings Hope to Mesothelioma Patients
- Low-Dose CT Screening May Increase Life Expectancy of Pleural Mesothelioma Patients
- Lung Biopsy is Crucial for Distinction Between Asbestos-Related Cancers
- Maintenance Therapies After Ovarian Cancer Treatment- Efficient But Expensive
- Mayo Clinic Validates Genomic Approach in Treating Gastric Cancer
- Nanoparticle Therapy Revolutionizes Cancer Treatment
- New ‘Interactome’ Maps Out Genetic Interactions in Mesothelioma
- New Delivery Method Cuts Mesothelioma Tumor Growth Significantly
- New Hope for Mesothelioma: Breakthroughs in Treatment Research
- New Mesothelioma Treatment Era with ADI-PEG20
- New Study Shows Surgery Can Improve Prognosis with Peritoneal Mesothelioma
- Niraparib Extends Life of Ovarian Cancer Patients, Says New Study
- NovoTTF-100LTM and Chemotherapy Approved by FDA
- Ovarian Cancer Patients Can Now Access Tumor Blocking Drug
- PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma
- Phase III Clinical Trial For Mesothelioma Shows Tumor Shrinkage
- Promising Immunotherapy Case for Peritoneal Mesothelioma
- Protein-Staining Test Can’t Distinguish Benign From Malignant Mesothelioma
- Researchers Identify Lymph Nodes As Significant Survival Indicator for Mesothelioma
- Significant Role of DFMO Treatment in Mesothelioma Adjuvant Therapy
- Spraying Oxaliplatin via PIPAC can Increase Survival of Peritoneal Mesothelioma
- Study Finds Lung-Sparing Surgery Improves Mesothelioma Survival
- Study: Immunotherapy Drug Buys Relapsed Meso Patients More Time
- Targovax’s Mesothelioma Candidate Shines in Latest Survival Data
- Team of Italian researchers suggest that three key biomarkers may be the key to response therapy
- Two Studies Examine Different Facets of Peritoneal Mesothelioma
- Ultrasound-Guided Needle Replaces Riskier Procedure
